(Date:11/20/2008)...derwent a mastectomy who undergo radiation therapy... tissue reconstruction provides fewer long-term co...e expander and implant reconstruction, according t...nal Journal of Radiation Oncology*Biology*Physics ... Therapeutic Radiology and Oncology., After under...
(Date:11/20/2008)...,s relatives at risk for hospital visits of their ...s) -- The stress of providing care for a loved one...caregivers having at least one emergency room or h...iversity study. , It,s long been recognized th...ult, but the Indiana University researchers said t...
(Date:11/20/2008)...truction Plan and Begins Marketing; John Strong, F...ing Group, Consorta, Inc., to Lead Sales and Marke...ire/ -- The world,s first permanent international ...pen in less than five years, the key players drivi...n Manhattan tower have been finalized and marketin...
(Date:11/20/2008)...e/ -- Want to lower your risk for type,2 diabetes...ake a big,difference. A study called the Diabetes...t 5 to 10 percent of your weight can prevent or de...d person, 5 percent is just 9,pounds. , In...diabetes, and heart,disease is the leading cause ...
Breaking Medicine News(10 mins):Health News:Type of breast reconstruction impacts radiation therapy outcomes 2Health News:When the Caregiver Becomes the Patient 2Health News:Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013 2Health News:Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013 3Health News:Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013 4Health News:Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013 5Health News:The 5-Percent Plan: Preventing Diabetes and Heart Disease 2...oved testing of small quantities of experimental d...rug clinical trial will be very helpful for resear... body and its efficacy if the drug is proved effec... proceed with a phase I clinical trial. Research...
... Canterbury has prompted reasons for concern among...en infected with the deadly virus since December. ...cases on an average per year. The source of the v...according to official health reports. There possib...
...the Indian State of Bihar has announced that a hea...troduced// in the state. An annual premium of Rs 2...ive members. This will serve to provide the family...nt health centers. Those who live below the pove...
...t and lung treatment centre at Golden Jubilee Hosp... lung surgery for patients across the west of Scot...it will also be a national centre for heart transp...,000 procedures a year will be performed at the ce...
Other Medicine News:(Date:11/19/2008)...critical enzyme,s regulation may hold key to under... , , MEMPHIS, Tenn., Nov. 19 /PRNewswire-US...search Hospital have gained new insights into regu...ed calpains. , , As the cell,s molecular o...rocesses, including the movement of cells in tissu...
(Date:11/19/2008)... a contract development and,manufacturing organiz...st,phase launch of its contract facility in Delaw...he process, facility and capacity problems commonl...ow-volume clinical and,early-stage commercial ste...n invest over $100 million and four years to devel...
(Date:11/18/2008)... NeuroDiscovery Ltd (ASX:,NDL), a specialty neuro...any,and Sosei Group Corporation ("Sosei"; TSE Mo...armaceutical company, today announce that NeuroSol... efficacy data for NSL-043/SD118.,This investigat...pain and has,successfully completed Phase I clini...
(Date:11/18/2008)...on Medical Resources (AMR), a,provider of premier...agnostic,imaging industries, finds that over $10 ... U.S. during the third quarter of 2008. Privigen i... (IVIG) and was launched in the first,quarter of ...sma of thousands,of donors and is used to treat i...
Breaking Medicine Technology:New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Isogen Launches Major New Facility to Address Global Biopharma Demand 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2First Lady Honors Women at International Womens Day Event 13817 1First Lady Honors Women at International Womens Day Event 13817 2Advanced Life Sciences Receives Nasdaq Notification 3796 1Advanced Life Sciences Receives Nasdaq Notification 3796 2Advanced Life Sciences Receives Nasdaq Notification 3796 3Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 13812 1Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 13812 2Researchers Design Promising Cancer Drug 13810 1Researchers Design Promising Cancer Drug 13810 2...indings Reported Safety & Tolerability Profile...ects --, CHICAGO, June 25, 2007 /PRNewswire-FirstC...annual meeting of the American Diabetes,Associatio...ipeptidyl-peptidase-4 (DPP-4) in development by Br...mbination with metformin,exhibited a statisticall...
... and SUNNYVALE, Calif., June 27, 2007,/PRNewswire-...preliminary results from two open-label, multi-cen...al use of Xcytrin(R),(motexafin gadolinium) Inject...ination with Alimta(R) (pemetrexed) and in,combina... treatment,for patients with non-small cell lung c...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 2Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 3Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 4Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 5Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
...-Mist™ HME product line has the right produc...s and from intubated patients to patients with tra...cation for both anesthesia and critical care appli...ide maximum protection for patients and staff memb...
...-Mist™ HME product line has the right produc...s and from intubated patients to patients with tra...cation for both anesthesia and critical care appli...ide maximum protection for patients and staff memb...
Passive heat and moisture exchangers for respiratory applications.
Medicine Products: